Aduro Biotech (ADRO) Names Jennifer Lew as CFO; Gregory W. Schafer to Step Down as COO
Tweet Send to a Friend
Aduro Biotech, Inc. (NASDAQ: ADRO) a biopharmaceutical company with three distinct immunotherapy technologies, today announced that Jennifer Lew has been ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
